In non-small cell lung cancer (NSCLC) [65] as well as in colorectal cancer [66], glucose transporter (GLUT1) is overexpressed in KRAS-mutated lung carcinomas in comparison with cells bearing wild-type KRAS. Here, SLC2A1 is linked to non-small cell lung carcinoma.